Neovasc to Report Second Quarter Financial Results on August 11, 2022
July 28 2022 - 9:00AM
via NewMediaWire – Neovasc Inc. (NASDAQ , TSX : NVCN), will
report financial results for the quarter ended June 30, 2022 on
Thursday, August 11, 2022. Neovasc’s President and Chief Executive
Officer Fred Colen, and Chris Clark, Chief Financial Officer, will
host a conference call to review the company’s results at 4:30 pm
EDT on August 11, 2022.
Interested parties may access the conference call by dialing
(877) 407-9208 or (201) 493-6784 (International) and reference
Conference ID 13730925. Participants wishing to join the call via
webcast should use the link posted on the investor relations
section of the Neovasc website at neovasc.com/investors/. A
replay of the webcast will be available approximately 30 minutes
after the conclusion of the call using the link on the Neovasc
website.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops and
markets products for the rapidly growing cardiovascular
marketplace. Its products include Reducer, for the treatment of
refractory angina, which is under clinical investigation in the
United States and has been commercially available in Europe since
2015, and Tiara™ for the transcatheter treatment of mitral valve
disease, which is currently under clinical investigation in the
United States, Canada, Israel and Europe. For more information,
visit: www.neovasc.com.
Forward-Looking Statement Disclaimer
Certain statements in this news release contain forward-looking
statements within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995 and applicable Canadian securities
laws that may not be based on historical fact. When used herein,
the words expect, anticipate, estimate, may, will, should, intend,
believe, and similar expressions, are intended to identify
forward-looking statements. Forward-looking statements may involve,
but are not limited to, the growing cardiovascular marketplace.
Forward-looking statements are based on estimates and assumptions
made by the Company in light of its experience and its perception
of historical trends, current conditions and expected future
developments, as well as other factors that the Company believes
are appropriate in the circumstances. Many factors could cause the
Company’s actual results, performance or achievements to differ
materially from those expressed or implied by the forward-looking
statements, including those described in the Risk Factors section
of the Company’s Annual Report on Form 20-F and in the Management’s
Discussion and Analysis for the three months ended March 31, 2022
(copies of which may be obtained at www.sedar.com or www.sec.gov).
These factors should be considered carefully, and readers should
not place undue reliance on the Company’s forward-looking
statements. The Company has no intention and undertakes no
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or
otherwise.
Contacts
InvestorsMike CavanaughWestwicke/ICRPhone: +1.617.877.9641Email:
Mike.Cavanaugh@westwicke.com
MediaSean LeousWestwicke/ICRPhone: +1.646.866.4012Email:
Sean.Leous@icrinc.com
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Sep 2023 to Sep 2024